Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,709.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 1,885.00
  • 52 Week Low: 1,135.00
  • Currency: UK Pounds
  • Shares Issued: 135.94m
  • Volume: 9,284
  • Market Cap: £2,323.22m
  • RiskGrade: 314

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 785.00 180.00 120.00¢ 2.0 n/a -35% n/a 0.0%
31-Dec-20 647.00 (173.00) 40.00¢ 17.1 n/a -67% n/a 0.0%
31-Dec-21 791.00 190.00 19.20¢ 84.3 n/a -52% n/a 0.0%
31-Dec-22 901.00 (95.00) (38.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1,093.00 1.00 1.00¢ 1,491.9 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 1,278.93 356.19 168.48p 10.1 0.0 +21,128% n/a 0.0%
31-Dec-25 1,396.54 428.87 213.48p 8.0 0.3 +27% n/a 0.0%
31-Dec-26 1,575.52 524.40 263.59p 6.5 0.3 +24% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 2.15 2.15 312.34 6.89

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Indivior Market Data

Currency UK Pounds
Share Price 1,709.00p
Change Today 4.00p
% Change 0.23 %
52 Week High 1,885.00
52 Week Low 1,135.00
Volume 9,284
Shares Issued 135.94m
Market Cap £2,323.22m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.04% below the market average55.04% below the market average55.04% below the market average55.04% below the market average55.04% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Price Trend
66.97% above the market average66.97% above the market average66.97% above the market average66.97% above the market average66.97% above the market average
85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average
Income Not Available
Growth
50.07% above the market average50.07% above the market average50.07% above the market average50.07% above the market average50.07% above the market average
8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
09:19 37 @ 1,709.00p
09:19 166 @ 1,709.00p
09:18 168 @ 1,709.00p
09:18 49 @ 1,709.00p
09:18 10 @ 1,709.00p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page